Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTP) Return on Assets (2023 - 2025)

Historic Return on Assets for 60 Degrees Pharmaceuticals (SXTP) over the last 3 years, with Q3 2025 value amounting to 1.47%.

  • 60 Degrees Pharmaceuticals' Return on Assets fell 1100.0% to 1.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.47%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 1.17% for FY2024, which is 3300.0% down from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Return on Assets stood at 1.47% for Q3 2025, which was down 1100.0% from 1.54% recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' 5-year Return on Assets high stood at 0.1% for Q1 2024, and its period low was 1.75% during Q1 2025.
  • In the last 3 years, 60 Degrees Pharmaceuticals' Return on Assets had a median value of 1.21% in 2024 and averaged 0.95%.
  • Data for 60 Degrees Pharmaceuticals' Return on Assets shows a peak YoY increase of -1100bps (in 2025) and a maximum YoY decrease of -16500bps (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows 60 Degrees Pharmaceuticals' Return on Assets stood at 0.45% in 2023, then tumbled by -168bps to 1.21% in 2024, then dropped by -22bps to 1.47% in 2025.
  • Its Return on Assets was 1.47% in Q3 2025, compared to 1.54% in Q2 2025 and 1.75% in Q1 2025.